» Articles » PMID: 10405786

Effect of Steroid Hormones on Blood Pressure

Overview
Specialties Pharmacology
Physiology
Date 1999 Jul 16
PMID 10405786
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

1. There is considerable evidence to support the idea that steroid hormones have the potential to increase blood pressure that may not always be via 'classical' mineralocorticoid or glucocorticoid action. 2. Epidemiological studies, together with the evidence from studies in animals, proposed the link between an adverse intra-uterine environment (i.e. undernutrition or excess exposure to glucocorticoids) and the early onset of cardiovascular and metabolic diseases later in life. 3. We tested this by treating pregnant ewes (and foetuses) with excess steroid early in pregnancy. The mean ages at which the prenatal exposure to glucocorticoid (dexamethasone 0.48 mg/h for 48 h) occurred were 22 +/- 0.4 to 29 +/- 0.4 days (prenatal treatment group 1; PTG1) and 59 +/- 2 to 66 +/- 2 days (PTG2), respectively. Basal blood pressures and hormones and the vascular responsiveness to graded doses of angiotensin II and noradrenaline, or to a 5-day adrenocorticotropin hormone treatment (ACTH), in lambs at 4, 10 and 19 months of age were studied. 4. Basal mean arterial pressure in PTG1 group (80 +/- 1 mmHg at 4 months; 83 +/- 1 mmHg at 10 months; and 89 +/- 1 mmHg at 19 months; n = 6) was significantly different (P < 0.05 in all groups) from that in the control group of lambs (74 +/- 2 mmHg at 4 months; 76 +/- 1 mmHg at 10 months; and 81 +/- 1 mmHg at 19 months; n = 7). Prenatal glucocorticoid exposure did not alter vascular responsiveness to noradrenaline, angiotensin II and ACTH in these sheep at any of the ages studied. 5. These results suggest that foetal exposure to maternal dexamethasone during defined developmental stage or 'window' programmes elevated blood pressure, which persists later in life.

Citing Articles

Effects of perioperative steroid use on surgical stress and prognosis in patients undergoing hepatectomy: a systematic review and meta-analysis of randomized controlled trials.

Zhong F, Yang H, Peng X, Zeng K Front Pharmacol. 2024; 15:1415011.

PMID: 39281283 PMC: 11393686. DOI: 10.3389/fphar.2024.1415011.


Diagnostic biomolecules and combination therapy for pre-eclampsia.

Qi J, Wu B, Chen X, Wei W, Yao X Reprod Biol Endocrinol. 2022; 20(1):136.

PMID: 36068569 PMC: 9446775. DOI: 10.1186/s12958-022-01003-3.


Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

McGoldrick E, Stewart F, Parker R, Dalziel S Cochrane Database Syst Rev. 2020; 12:CD004454.

PMID: 33368142 PMC: 8094626. DOI: 10.1002/14651858.CD004454.pub4.


Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Roberts D, Brown J, Medley N, Dalziel S Cochrane Database Syst Rev. 2017; 3:CD004454.

PMID: 28321847 PMC: 6464568. DOI: 10.1002/14651858.CD004454.pub3.


Antenatal steroids for fetal lung maturity: Time to target more frequent doses to fewer women?.

Freeman C, Hezelgrave N, Shennan A Obstet Med. 2016; 8(4):172-6.

PMID: 27512476 PMC: 4935049. DOI: 10.1177/1753495X15601772.